Parkinson’s disease (PD) is a progressive neurodegenerative condition clinically identified by the hallmark features of shaking, stiffness and slowness. PD is also marked by a multitude of non-motor symptoms like constipation, cognitive changes and sleep disorders. Any number of symptoms and intensities can exist in each patient, leading to a remarkably heterogenous patient population. While effective symptomatic treatments exist, the only known means of quantitatively slowing progression to date is exercise, specifically cardiovascular exercise that increases heart rate (1).